Association between volume and cost in low‐resection volume regions: a population‐level study on pancreatoduodenectomy for pancreatic cancer patients

Ling Li,Nanda Aryal,Khalia Ackermann,Neil Merrett,Arthur Richardson,Johanna I Westbrook,Susan Dunn,Vincent Lam
DOI: https://doi.org/10.1111/ans.19273
IF: 1.7
2024-10-20
ANZ Journal of Surgery
Abstract:The median total cost of patients undergoing pancreaticoduodenectomies (PDs) at high‐volume hospitals was 88% of the median cost at low‐volume hospitals. This inverse relationship held true after adjusting for patient and clinical factors. Similarly, the three major cost components: employee cost, operating cost, and other costs, were all lower at high‐volume hospitals. Background Pancreatoduodenectomy (PD) is a highly complex, invasive, and costly surgical procedure. Limited evidence on the PD volume‐cost relationship in countries with a low population density exists. This study aimed to investigate this issue in Australia. Methods This retrospective cohort study included pancreatic cancer patients who had a PD at any public hospital in New South Wales, Australia between 2016 and 2019. The primary outcome was the total hospital cost during PD admission (not including patient financial burden). Study hospitals were grouped into low‐volume hospitals (LVHs; <10 PDs per annum) or high‐volume hospitals (HVHs). Multivariable modelling was applied to examine the association between volume and cost. Results Of 443 PDs, the median total hospital cost per patient at HVHs was AU 62859; P = 0.001). After adjusting for available patient and clinical factors, the total cost per patient at LVHs was 22% higher than that of HVHs (adjusted estimate: 1.22, 95% CI: 1.08–1.37; P = 0.002). Similar patterns were found in three main cost components: 24% higher employee cost at LVHs than at HVHs (1.24, 95% CI: 1.10–1.41; P
surgery
What problem does this paper attempt to address?